Active Ingredient History
Lipid emulsion or fat emulsion refers to an emulsion of lipid for human intravenous use, especially catering critically-ill patients that cannot consume food and administer their required nutrients enterally. It is often referred to by the brand name of the most commonly used version, Intralipid, which is an emulsion of soy bean oil, egg phospholipids and glycerin, and is available in 10%, 20% and 30% concentrations. The 30% concentration is not approved for direct intravenous infusion, but should be mixed with amino acids and dextrose as part of a total nutrient admixture. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abortion, Habitual (Phase 4)
Abortion, Spontaneous (Phase 4)
Anesthesia (Phase 4)
Atrial Fibrillation (Phase 3)
Blood Pressure (Early Phase 1)
Child Nutrition Disorders (Phase 4)
Cholestasis (Phase 4)
Crohn Disease (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Enteral Nutrition (Phase 2)
Esophageal Atresia (Phase 2)
Fatty Acids (Phase 4)
Gastroschisis (Phase 2)
General Surgery (Phase 4)
Healthy Volunteers (Phase 4)
Hypertension (Phase 4)
Ileus (Phase 4)
Infant, Premature (Phase 4)
Infant, Premature, Diseases (Phase 2)
Infertility (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 2/Phase 3)
Intestinal Atresia (Phase 2)
Intestinal Diseases (Phase 2)
Intestinal Failure (Phase 2)
Intestinal Neoplasms (Phase 3)
Kernicterus (Phase 2)
Malnutrition (Phase 4)
Metabolic Diseases (Phase 2/Phase 3)
Metabolic Syndrome (Phase 4)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 4)
Pancreatic Neoplasms (Phase 4)
Parenteral Nutrition (Phase 4)
Pregnancy Complications (Phase 4)
Psychomotor Disorders (Phase 4)
Reperfusion Injury (Phase 2/Phase 3)
Respiratory Distress Syndrome (Phase 2)
Short Bowel Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue